Join to View Full Profile
330 Brookline AveKs-457Boston, MA 02215
Phone+1 617-667-4460
Fax+1 617-667-7919
Are you Dr. Schachter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Steven Schachter, MD is a board certified neurologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is a Professor of Neurology at Beth Israel Deaconess Medical Center.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1981 - 1984
University of North Carolina HospitalsInternship, Internal Medicine, 1980 - 1981
Case Western Reserve University School of MedicineClass of 1980
Certifications & Licensure
MA State Medical License 1982 - 2023
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Management recommendations to reduce cardiac risk in chronic epilepsy.Trudy D Pang, Richard L Verrier, Steven C Schachter
Epilepsy & Behavior Reports. 2025-03-01 - The Shift to Over-the-Counter Diagnostic Testing After RADx: Clinical, Regulatory, and Societal Implications.Maren Downing, John Broach, Wilbur Lam, Yukari C Manabe, Greg Martin
IEEE Open Journal of Engineering in Medicine and Biology. 2025-01-01 - 6 citationsExome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes.Siwei Chen, Bassel W Abou-Khalil, Zaid Afawi, Quratulain Zulfiqar Ali, Elisabetta Amadori
Medrxiv. 2024-09-20
Press Mentions
NIH MedTech Program Aims to Accelerate Medical Devices to Treat, Diagnose Nervous System DisordersNovember 21st, 2022
LivaNova VNS Therapy System for Drug-Resistant Epilepsy Could Save $77,000 Per Patient over Five YearsSeptember 4th, 2018
LivaNova Launches Global Clinical Registry to Assess VNS Therapy Treatment for Drug-Resistant Epilepsy PatientsAugust 24th, 2018- Join now to see all
Grant Support
- Center for Innovative NeuroTech Advancement - CINTAMASSACHUSETTS GENERAL HOSPITAL2022–2027
- Center for Innovative NeuroTech Advancement - CINTAMASSACHUSETTS GENERAL HOSPITAL2022–2027
- Center for Innovative NeuroTech Advancement - CINTAMASSACHUSETTS GENERAL HOSPITAL2022–2027
- Center for Innovative NeuroTech Advancement - CINTAMASSACHUSETTS GENERAL HOSPITAL2022–2027
- Center for Innovative NeuroTech Advancement - CINTAMASSACHUSETTS GENERAL HOSPITAL2022–2027
- RADX INNOVATION FUNNEL FOR HIV DIAGNOSTICS - COORDINATION CENTERMASSACHUSETTS GENERAL HOSPITAL2024–2025
